| |
| |
|
| Insider
Information: |
Sutton Gregg S |
| Relationship: |
VP of Research and Dev... |
| City: |
Minneapolis |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
43,551 |
|
|
Indirect Shares
|
5,000 |
|
|
| Direct
Value |
$842,016 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,551 |
|
|
| Total
Value |
$842,016 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vascular Solutions Inc |
VASC |
VP R&D |
2006-01-25 |
18,288 |
2006-01-25 |
5,000 |
Premium* |
|
|
Surmodics Inc |
SRDX |
VP of Research and Dev... |
2019-11-30 |
25,263 |
2016-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2019-11-30 |
4 |
D |
$41.04 |
$16,950 |
D/D |
(413) |
25,263 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2019-11-28 |
4 |
D |
$40.89 |
$28,091 |
D/D |
(687) |
25,676 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2019-11-27 |
4 |
D |
$40.89 |
$16,479 |
D/D |
(403) |
26,363 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2018-11-30 |
4 |
D |
$60.59 |
$25,024 |
D/D |
(413) |
16,403 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2018-11-28 |
4 |
D |
$60.06 |
$41,261 |
D/D |
(687) |
16,816 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2018-11-27 |
4 |
D |
$56.63 |
$234,561 |
D/D |
(4,142) |
17,503 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,731 |
21,645 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2018-08-23 |
4 |
S |
$74.11 |
$1,099,093 |
D/D |
(14,824) |
9,309 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2018-08-23 |
4 |
OE |
$19.42 |
$307,270 |
D/D |
14,824 |
24,133 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2017-11-30 |
4 |
D |
$33.10 |
$14,432 |
D/D |
(436) |
8,812 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2017-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,518 |
9,248 |
0 |
- |
|
| SRDX |
Surmodics Inc |
VP of Research and Development |
• – – |
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,713 |
3,477 |
0 |
- |
|
| VASC |
Vascular Solutions Inc |
officerTitle |
• – – |
2006-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
16,644 |
|
- |
|
| VASC |
Vascular Solutions Inc |
VP of R and DOfficer |
• – – |
2004-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
